Category: CBD Stocks
2 Stocks Down More Than 90% That Still Aren’t Worth Buying
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 182% for the…
Neural Therapeutics Acquires Stake in German CBD Retailer Hanf.com
An announcement from Neural Therapeutics Inc. ( ($TSE:NURL) ) is now available. Neural Therapeutics Inc. has completed the acquisition of…
CenTex CBD is closing their doors amidst uncertainty and political debate
The ongoing battle to ban THC in Texas led to their decision.
Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure
CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.
CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels
Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration SCOTTSDALE, AZ…
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of …
Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.
Flora Growth Corp. (FLGC) Leaps Into Web3 With $1M Crypto Bet
Flora Growth Corp. (NASDAQ:FLGC) is among the cheap pot stocks to buy. It is a global cannabis company headquartered in…
Artelo Biosciences stock surges after receiving favorable UK regulatory guidance
Investing.com — Artelo Biosciences (NASDAQ: ARTL) stock surged 18% after the company received favorable guidance from the UK’s Medicines and…
INVESCO Ltd. stock underperforms Wednesday when compared to competitors
Shares of INVESCO Ltd. IVZ slid 1.10% to $21.48 Wednesday, on what proved to be an all-around rough trading session…
Why value investing has worked better outside the US
While value has outperformed growth in Europe over the past five years, Europe now represents less than half of equity…
Recent Comments